StockData
Biodesix Inc logo

Biodesix Inc (BDSX) income statement

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.30−0.10 (-1.19%)

Close on Nov 19, 2026Market cap $87.57MP/E –Yield –

See a number that looks wrong?